Biotech Losing Streak Continues (IBB)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Why BofA says July Fed rate hike would be "unprecedented"
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Argus Upgrades Vertex (VRTX) to Buy
September 28, 2015 8:01 AM EDTArgus upgraded Vertex (NASDAQ: VRTX) from Hold to Buy with a price target of $126.00, saying they have been waiting for a pullback to upgrade the shares.
The analyst notes shares have declined 16% in the past week, as investors rotated out of Biotech stocks over... More
